knowledge -WSS

knowledge

author：entertainment 2025-10-01 00:46:55 - browse：672

empty test tubes in the hand. -- first opinion coverage from STAT — Adobe

The Food and Drug Administration on Friday announced its intention to start regulating tests developed in laboratories — closing the “Theranos loophole” that has allowed inaccurate tests to slip through the cracks.

Lawmakers came close last year to passing a bill that would have given the FDA this authority, but it was ultimately rejected by Republicans who sympathized with the labs in academic medical centers and hospitals that opposed the provision. FDA Commissioner Robert Califf said at the time that if the bill failed, the agency would take matters into its own hands.

The proposed rule fulfills that promise, adding lab diagnostics to the list of devices that fall under FDA enforcement — a move that patient groups and non-lab test makers support, and that laboratories are likely to dispute. When the FDA started regulating medical devices in 1976, lab-developed tests were simple and offered mostly to local patient populations. The agency generally allowed labs to use these tests without submitting proof of their efficacy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Publishing genetic code of viruses could cause disaster

WSS

Studies point to risks of excluding people with obesity from drug trials

Healthy food access boosts outcomes in two studies

Will Ozempic

A letter from the executive editor: STAT UnitedHealth investigation

Solve the antibiotic resistance crisis with preventive drugs

HHS leader on health, climate change and biopharma emissions

leisure time

knowledge

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

Beam Therapeutics to lay off 20% of its staff, re

Guidelines to prevent youth baseball injuries need more muscle

NIH chief: government has fallen behind pharma on clinical trials

How one medical school became remarkably diverse

Solve the antibiotic resistance crisis with preventive drugs

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Lawmakers consider Medicare pay reforms for doctors

Dobbs anniversary: the lost opportunity of abortion as health care

CVS, Rite Aid closures threaten to worsen pharmacy deserts

focus

Ventyx halts psoriasis drug development after lackluster trial results

Solve the antibiotic resistance crisis with preventive drugs

Type 2 diabetes prevention programs work at large scale: study

NIH chief: government has fallen behind pharma on clinical trials

STAT Summit: GSK CEO on pharma giant's new direction

Ohio still needs to do more to protect the right to abortion

focus

hotspot

knowledge

explore